TREATMENT OF RHEUMATIC DISEASES INTERRELATION OF SELECTIVE NON-STEROIDAL ANTIINFLAMMATORY DRUG CELEBREX (CELECOXIB) AND INHIBITOR OF ENZYME WITH APF ENAP (ENALAPR1L) IN PATIENTS WI...

by Yu. V. Mouraviev, T N Tsapina, L N Kashnikova
Published 2002-06-01

CLINICAL AND FUNCTIONAL FEATURES OF PANCREAS STATE IN RHEUMATOID ARTHRITIS

by O. O. Basieva, S. G. Radenska-Lopovok, L N Kashnikova
Published 2000-02-01

EFFEKTIVNOST' SORBIFERA DURU LES PRI DEFITsITE ZhELEZA U BOL'NYKh RA S ANEMIEY

by E A Galushko, Yu V Murav'ev, L N Kashnikova
Published 2000-08-01

Role of hepcidin in the development of anemia in patients with rheumatoid arthritis

by Elena Andreyevna Galushko, D A Belenky, E N Aleksandrova, L N Kashnikova
Published 2012-06-01

Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

by N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, L N Kashnikova, T A Temnikova, E L Nasonov
Published 2019-05-01

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis

by S. S. Shabanova, L. P. Ananjeva, T. V. Popkova, E. S. Mach, D. S. Novikova, M. N. Starovoytova, L. N. Kashnikova, E. L. Nasonov
Published 2016-05-01